When was Biotage founded?

Biotage was founded in 1989 and raised its 1st funding round 26 years after it was founded.

Where is Biotage located?

Biotage is headquartered in Uppsala, Sweden. It is registered at Vimpelgaten 5, SE-753 18 UPPSALA.

Who is the current CEO of Biotage?

Frederic Vanderhaegen of Biotage.

How many employees does Biotage have?

As of May 31, 2026, the latest employee count at Biotage is 526.

Is Biotage a funded company?

Biotage is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2015.

When was the latest funding round of Biotage?

Biotage's latest funding was a $***** Grant (prize money) round on Jan 01, 2017, with participation from 1 investor.

Where does Biotage rank among its competitors?

Biotage ranks 3rd amongst 370 active competitors, of which 41 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Biofortuna, which secured $303K in Feb, 2026.

Who are the top competitors of Biotage?

Biotage's top competitors include Novartis, Catalent and Tirupati Medicare. Among them, Biofortuna secured the most recent funding round in February, 2026.

Biotage - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Organic synthesis, analytical, and peptide chemistry services for drug discovery and development. It also offers efficient separation technologies from analysis to industrial scale and high quality medical, analytical and peptide chemistry solutions for research and commercial-scale application. The products are utilized by government agencies, academic institutions, pharmaceutical organizations, and food industry entities, among others.

Website: www.biotage.com/
Social
Email ID: *****@biotage.com
Phone Number: +46 **********
Registered Address: Vimpelgaten 5, SE-753 18 UPPSALA

Key Metrics

Founded Year

1989

Location

Uppsala, Sweden

Stage

Acquired

Latest Funding Round

Grant (prize money), Jan 01, 2017, $*****

Investors

Taaleri & 5 more

Ranked

3^rd among 370 active competitors

Employee Count

526 as on May 31, 2026

Investment & Acquisitions

Astrea Bioseparations & 5 more

Similar Companies

Novartis & 422 more

Exit Details

Acquired by KKR (Apr 22, 2025)

View Biotage's full profile

Biotage is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Biotage Ab CIN: 556539-3138 , Sweden, Active	Mar 06, 1997	$155M (As on Dec 31, 2022)	-	-
BIOTAGE SWEDEN AB CIN: 925737402 , Norway, Active	Apr 29, 1994	-	-
BIOTAGE INDIA PRIVATE LIMITED CIN: U74999DL2017FTC364509 , India, Active	Oct 11, 2017	$1.47M (As on Mar 31, 2025)	14 (As on Aug 01, 2025)

Biotage got acquired by KKR on Apr 22, 2025.

Click here to take a look at Biotage's acquisition in detail

Biotage has raised funding over 2 rounds. Its first funding round was on 2015. Its latest funding round was a Grant (prize money) round on Jan 01, 2017 for $*****. 1 investor participated in its latest round. Biotage has 6 institutional investors.

Here is the list of recent funding rounds of Biotage:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 01, 2017	3255717	Grant (prize money)	9510338	3189303	1901710	6618868
2015	4423	Grant (prize money)	7178	8706	5558	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Biotage's funding rounds and investors

Biotage's employee count trend

Biotage has 526 employees as of May 26. Here is Biotage's employee count trend over the years:

Uncover Biotage's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biotage include Novartis, Catalent and Tirupati Medicare. Here is the list of Top 10 competitors of Biotage, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Novartis 1996, Basel (Switzerland), Public	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, MT Capital & 9 others	70/100
2nd	Catalent 2007, Somerset (United States), Acquired	Provider of development, manufacturing, and packaging solutions for medicines and supplements	-	Aisling Capital, Genstar Capital & 3 others	68/100
3rd	Biotage 1989, Uppsala (Sweden), Acquired	Organic synthesis, analytical, and peptide chemistry services for drug discovery and development	-	Taaleri, Investor Growth Capital & 4 others	64/100
4th	Tirupati Medicare 1980, Paonta Sahib (India), Series B	Contract manufacturer of pharmaceutical products	$51.5M	internationalcylinders.com, TBO & 26 others	59/100
5th	Surrozen 2016, San Francisco (United States), Public	Pioneering targeted regenerative antibodies to repair tissue and restore organ function	$133M	The Column Group, Horizons Ventures & 13 others	59/100
6th	BioFactura 2004, Frederick (United States), Series B	Biosimilars, biodefense, and biomanufacturing company dedicated to innovation and global biomedical needs	$7.8M	Wilson Sonsini Goodrich & Rosati, UVM Health ... & 2 others	56/100
7th	Biofortuna 2008, Birkenhead (United Kingdom), Series A	Provider of manufacturing services for immunoassays, molecular diagnostics, and regulatory services	$21.6M	Foresight Group, Catapult Ventures & 12 others	55/100
8th	Acclinate 2020, Birmingham (United States), Series A	Provider of clinical trial services to biopharma sector	$15.5M	Cencora, Alabama Launchpad & 7 others	55/100
9th	AmplifyBio 2021, Hilliard (United States), Deadpooled	Provider of contract research, development, and manufacturing services for biologic drugs	$230M	Hercules Capital, Casdin Capital	53/100
10th	Sunflower Therapeutics 2018, Hingham (United States), Series A	Provider of drug development & research services for multiple therapeutic areas	$5.64M	NIAID, Clear Current Capital & 3 others	52/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Biotage's competitors? Click here to see the top ones

Biotage has not made any investments yet. Biotage has made 6 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Feb 28, 2023	Acquisition	Astrea Bioseparations	1987	Cambridge (United Kingdom)
Oct 20, 2021	Acquisition	ATDBio	2005	Southampton (United Kingdom)
Dec 04, 2018	Acquisition	PhyNexus	2002	San Jose (United States)